Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly

ConclusionThe sAOT is a good predictor tool for assessing response to SRLs and correlates with tumor E-cadherin and SSTR2 expression. Thus, it can be useful in clinical practice for therapeutic decision-making in patients with acromegaly.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research